PLUS

HEADLINES TREATMENT REGIMENS FROM THE ADVISORY BOARD PUBLISHERS ALLIANCE TOOLS MULTIMEDIA CME

PROSTVAC: Targeted Prostate Cancer Immunotherapy

Neal D. Shore, MD, FACS, sits down with CTA to discuss PROSTVAC as a targeted immunotherapy for prostate cancer.

ARZERRA® (ofatumumab) for CLL

This slideshow reviews drug info for ARZERRA® (ofatumumab).

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Case: Male Presents with ADT Resistance

A patient’s PSA remained increased throughout ADT. Best treatment?

CLEOPATRA Ups HER2+ Breast Cancer Survival

Addition of pertuzumab to traztuzumab + docetaxel ups overall survival.

Case: Man With Right-Sided Facial Swelling

A man presents with facial swelling; determine the best imaging study to use.

NANETS 2014 Symposium Coverage

Live coverage of the NANETS 2014 Symposium.

How Do Your Reading Habits Compare?

We polled readers about how often they read oncology news.

Viewpoints

CLEOPATRA Reveals New Treatment Option for HER2+ Breast Cancer Patients

CLEOPATRA Reveals New Treatment Option for HER2+ Breast Cancer Patients

Addition of pertuzumab to traztuzumab + docetaxel added almost 16 months to overall survival compared to those who didn't receive pertuzumab.

Does Regulatory Bureaucracy Drive Disparities in Cancer Drug Access Around the World?

Does Regulatory Bureaucracy Drive Disparities in Cancer Drug Access Around the World?

Regional disparities in cancer drug access have complex causes, including bureaucratic differences and variation in health care spending.

Feature Articles

Risks and Benefits of Phase 1 Clinical Trial Participation

Risks and Benefits of Phase 1 Clinical Trial Participation

[Cancer Control] Research derived from phase 1 clinical trials can be vital to the development of new treatments. There are long-lasting positive and negative impacts on those patients who choose to participate in phase 1 clinical trials, but participant safety is a priority.

Treating advanced melanoma: Current insights and opportunities

Treating advanced melanoma: Current insights and opportunities

[Cancer Management and Research] Although thin melanomas have an excellent prognosis after sufficient surgical treatment, melanoma disease in advanced stages still proves to be a therapeutic challenge. In the last several years, new therapeutic strategies have emerged.

Human Papilloma Virus and Squamous Cell Carcinoma of the Anus

Human Papilloma Virus and Squamous Cell Carcinoma of the Anus

[Clin Med Insights Oncol] HPV is a risk factor for anal intraepithelial neoplasia (AIN). The etiology, anatomy, pathogenesis, management of squamous cell carcinoma (SCC) are discussed.

Featured Videos

Fall Digital Issue

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs